Despite the size and visibility of the community — and the call for diverse patient research — there remains a gap in available health data specific to the Sikh community in the U.S.
- Pharma Procurement Can Make Or Break Startups: Let's Help Mature Our Future Partners To Secure Innovation
- Becoming A Backbone Therapy: Lessons Learned With Actuate Therapeutics
- Building Patient Trust In Research Through Connection Driven-Transparency
- How To Lead A Moonshot Collaboration: Lessons From Over A Decade Of Competitors Working Together
- Patient Trust In Pharma Is Low; Here's How To Rebuild It
- Why Dr. Robert Califf Isn't Pulling His Punches Anymore
- The U.S. Trial Advantage Is Eroding
GUEST COLUMNISTS
-
![American Flag-GettyImages-2256012795]( "The U.S. Trial Advantage Is Eroding")
The U.S. Trial Advantage Is ErodingOnce the go-to location for trials, the U.S. is now seeing competition from APAC, driven by political, economic, and workforce pressures domestically and rapid growth abroad.
-
![Machine learning, ai, aertificial intelligence-GettyImages-2216092983]( "Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI")
Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AILearn why the next frontier in AI governance will involve real-time surveillance of algorithmic performance across institutions with guidance from Akshaya Bhagavathula and Michelle A. Williams.
-
![Lessons Learned-GettyImages-835037356]( "Want To Optimize Clinical Project Team Performance? Try This Formal 'Lessons Learned' Process")
Want To Optimize Clinical Project Team Performance? Try This Formal 'Lessons Learned' ProcessLearn how a formal "lessons learned" process can help teams work collaboratively with open, honest, and timely communication to reach thoughtful decisions that lead to on-time, on-budget, and inspection-ready trials.
-
![Number 4-GettyImages-1458365060]( "4 Factors Changing The Way CRAs Monitor Trials")
4 Factors Changing The Way CRAs Monitor TrialsThe way CRAs monitor is about to change. Regeneron's Patrick Floody discusses these four factors that will influence it.
-
![Business Quality Assurance and Compliance-GettyImages-2225358412]( "How Can AI Change Computerized System Validation?")
How Can AI Change Computerized System Validation?Learn how AI technologies are changing the computer system validation (CSV) landscape and what you need to understand about this transformation.
-
![bechtel getz series article 2]( "Too Little Info, Too Much Time Wasted: Feasibility Challenges For Sites")
Too Little Info, Too Much Time Wasted: Feasibility Challenges For SitesIncomplete protocols, lengthy sponsor decision timelines, and uncompensated work plague clinical research sites. Learn why these issues exist and how to address them alongside experts from SCRS and Tufts CSDD.
-
![digital platform, artificial intelligence, machine learning, processing for mental health-GettyImages-2234202465]( "Will New AI Health Assistants Suggest Clinical Trials To Inquiring Patients?")
Will New AI Health Assistants Suggest Clinical Trials To Inquiring Patients?New AI health assistants are now doing even more to help patients make sense of symptoms, diagnoses, and treatment options. What does that mean for the discoverability of clinical trials?
-
![Diverse business team-GettyImages-2198573359]( "What CROs Do Right Isn't Always Obvious To Research Sites")
What CROs Do Right Isn't Always Obvious To Research SitesCROs are doing many things right. But it's when that right thing is understood — not just executed — that the impact becomes far greater than compliance alone.
CLINICAL TRIAL WHITE PAPERS
-
![GettyImages-2195709732-digital-transformation-gear-technology]( "Tracking Functional Capacity To Advance Neuromuscular Disease Research")
Tracking Functional Capacity To Advance Neuromuscular Disease ResearchThis presentation introduces a dual-endpoint approach to monitoring neuromuscular disease progression through two high-centile digital measures.
-
Streamlining Clinical Trial Start-Up In Australia10/20/2025
Gain a comprehensive overview of how sponsors can accelerate clinical trial start-up in Australia, leveraging the nation’s unique strengths as a global hub for clinical research.
-
What Is Healthcare Data Interoperability And Why Does It Matter For Clinical Research?1/28/2025
Explore how healthcare data interoperability can transform patient outcomes, streamline clinical research, and enhance efficiencies while addressing key challenges and global initiatives.
-
Strategies For Post-Approval Lifecycle Management And Local PV7/12/2024
If you are unsure of how to navigate your post-approval regulatory journey, an experienced regulatory services partner can provide support to help you identify and achieve post-approval goals.
-
Unpacking FDA's Final Rule To Regulate LDTs3/14/2025
Discover how the FDA's rule redefines diagnostic testing by classifying laboratory-developed tests (LDTs) as medical devices to ensure stricter oversight and consistent standards for safety and efficacy.
-
A New, AI-Augmented Horizon For Safety And Pharmacovigilance1/6/2026
Is your organization leveraging AI to maximize efficiency in safety and regulatory workflows? If not, explore how these technologies are slated to improve industry approaches in 2026.
CLINICAL TRIAL APP NOTES & CASE STUDIES
-
Pay-By-Procedure Vs. Pay-By-Visit12/8/2025
Explore how a pay-by-procedure model can reshape site payments, enhance transparency, and reveal meaningful efficiencies across complex clinical trials.
-
Reducing The Burden Of Patient Retention And Improving Continuity1/6/2026
Immunology trials often place a sustained burden on participants. However, integrating Home Trial Support (HTS) into a Phase 3 immunology trial can help improve the overall study experience.
-
How To Recruit 236 Patients In An Osteoarthritis Study On Time During The Peak Of The Pandemic7/23/2024
A leading Eastern European contract research organization completed the recruitment of 236 subjects in a Phase 3 osteoarthritis study for Handok Inc. despite hurdles caused by the COVID-19 pandemic.
-
Study Analysis – Site Payment Automation12/8/2025
By removing administrative bottlenecks, see how automation improves cash flow for sites, reduces operational burden for sponsors, and supports smoother, more predictable trial execution.
-
The Perfect Solution For Recruitment, Retention, And ROI8/15/2024
See how Citeline Connect was deployed to advance enrollment six months ahead of schedule for a sponsor’s Phase IV atopic dermatitis trial and build a community of engaged patients.
-
How Pfizer Used Wearable DHTs To Reveal Meaningful Treatment Effects In Cancer Cachexia11/20/2024
Wearable digital health technologies (DHTs) played a crucial role in assessing patient-centric outcomes during pfizer's study into the benefits of using ponsegromab for treating cancer cachexia.
NEWSLETTER ARCHIVE
- 02.09.26 -- Why The EU Biotech Act Matters To The U.S.: A Clinical Perspective
- 02.06.26 -- 4 Factors Changing The Way CRAs Monitor Trials
- 02.06.26 -- Pave The Way To Clinical Trial Operation Success
- 02.05.26 -- What To Watch For In The 2026 Clinical Trial Landscape
- 02.04.26 -- Is Your Team Burnt Out? Discover The ROI Of Healthy Employees Running Trials
RECRUITMENT AND DIVERSITY
This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.
-
![Medical examination of woman using ultrasound equipment of liver kidneys-GettyImages-1482783655]( "Building Patient Trust In Research Through Connection Driven-Transparency")
The question is not whether trust matters but how industry, sponsors, and investigators can bridge the trust gap to drive patient participation.
-
![Healthcare Questions-GettyImages-2193936936]( "Patient Trust In Pharma Is Low; Here's How To Rebuild It")
CISCRP's Annick de Bruin and Shalome Sine provide strategies for building patient trust based on the findings from their Perceptions & Insights Study.
-
![American Flag-GettyImages-2256012795]( "The U.S. Trial Advantage Is Eroding")
Once the go-to location for trials, the U.S. is now seeing competition from APAC, driven by political, economic, and workforce pressures domestically and rapid growth abroad.
FOCUS ON PATIENTS
-
![Fun while washing hands-GettyImages-2217454730]( "The FDA Calls For Culturally-Informed Research, But What Do We Understand About The Sikh Community?")
Despite the size and visibility of the community — and the call for diverse patient research — there remains a gap in available health data specific to the Sikh community in the U.S.
-
![Manager checking expiration dates in drugstore-GettyImages-1666055443]( "The Key Role Of Clinical Supply Teams In Patient Centricity Efforts")
Clinical supply decisions shape patient access, safety, and trial success. From logistics to procurement, patient-centric supply can accelerate therapies or quietly delay them.
-
![Medical examination of woman using ultrasound equipment of liver kidneys-GettyImages-1482783655]( "Building Patient Trust In Research Through Connection Driven-Transparency")
The question is not whether trust matters but how industry, sponsors, and investigators can bridge the trust gap to drive patient participation.
